Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2016 Volume 14 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2016 Volume 14 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats

  • Authors:
    • Francisco Peralta
    • Constanza Fuentealba
    • Jenny Fiedler
    • Esteban Aliaga
  • View Affiliations / Copyright

    Affiliations: Department of Kinesiology, Faculty of Health Sciences, Universidad Católica del Maule, Talca 3460000, Chile, Department of Biochemistry and Molecular Biology, Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, Santiago 8380000, Chile
  • Pages: 2807-2814
    |
    Published online on: July 18, 2016
       https://doi.org/10.3892/mmr.2016.5529
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder characterized by deficits in social communication and social interaction, and repetitive and stereotypical patterns of behavior. Previously, a common physiopathological pathway, involving the control of synaptic protein synthesis, was proposed as a convergence point in ASD. In particular, a role for local mRNA translation activated by class I metabotropic glutamate receptor type 5 (mGluR5) was suggested in genetic syndromes with autistic signs and in the prenatal exposition to the valproate model of autism. However, the role of the other members of class I metabotropic glutamate receptors, including mGluR1, has been poorly studied. The present study analyzed the immunoreactivity for mGluR1a in the hippocampus of rats prenatally treated with valproate. Pregnant dams (embryonic day 12.5) were injected with valproate (450 mg/kg) and subsequently, the behavior and mGluR1a were evaluated at postnatal day 30. Experimental rats exhibited social deficit, repetitive conduct and anxious behaviors compared with that of the control animals. Additionally, the present study observed an increased level of mGluR1a-immunoreactivity in the hilus of dentate gyrus and in the CA1 alveus region of the hippocampus. These results suggested an over‑functioning of mGluR1a signaling in the hippocampus, induced in the valproate model of autism, which may serve a role in cognitive and behavioral signs of ASD.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Frith U and Happé F: Autism spectrum disorder. Curr Biol. 15:R786–R790. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Wass S: Distortions and disconnections: Disrupted brain connectivity in autism. Brain Cogn. 75:18–28. 2011. View Article : Google Scholar

3 

Blatt GJ: The neuropathology of autism. Scientifica (Cairo). 2012:7036752012.

4 

Betancur C: Etiological heterogeneity in autism spectrum disorders: More than 100 genetic and genomic disorders and still counting. Brain Res. 1380:42–77. 2011. View Article : Google Scholar

5 

Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, et al: Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet. 34:27–29. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P and Scherer SW: Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet. 81:1289–1297. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsäter H, et al: Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 39:25–27. 2007. View Article : Google Scholar :

8 

Hung AY, Futai K, Sala C, Valtschanoff JG, Ryu J, Woodworth MA, Kidd FL, Sung CC, Miyakawa T, Bear MF, et al: Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci. 28:1697–1708. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Dindot SV, Antalffy BA, Bhattacharjee MB and Beaud: The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet. 17:111–118. 2008. View Article : Google Scholar

10 

Kishino T, Lalande M and Wagstaff J: UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 15:70–73. 1997. View Article : Google Scholar : PubMed/NCBI

11 

Sadakata T, Washida M, Iwayama Y, Shoji S, Sato Y, Ohkura T, Katoh-Semba R, Nakajima M, Sekine Y, Tanaka M, et al: Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients. J Clin Invest. 117:931–943. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Costa-Mattioli M, Sossin WS, Klann E and Sonenberg N: Translational control of long-lasting synaptic plasticity and memory. Neuron. 61:10–26. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Hoeffer CA and Klann E: mTOR signaling: At the crossroads of plasticity, memory and disease. Trends Neurosci. 33:67–75. 2010. View Article : Google Scholar

14 

de Vries PJ and Howe CJ: The tuberous sclerosis complex proteins-a GRIPP on cognition and neurodevelopment. Trends Mol Med. 13:319–326. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D and Warren ST: Translational suppression by trinucleotide repeat expansion at FMR1. Science. 268:731–734. 1995. View Article : Google Scholar : PubMed/NCBI

16 

Koekkoek SK, Yamaguchi K, Milojkovic BA, Dortland BR, Ruigrok TJ, Maex R, De Graaf W, Smit AE, VanderWerf F, Bakker CE, et al: Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron. 47:339–352. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R and Eng C: Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 42:318–332. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Goffin A, Hoefsloot LH, Bosgoed E, Swillen A and Fryns JP: PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet. 105:521–524. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Zori RT, Marsh DJ, Graham GE, Marliss EB and Eng C: Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet. 80:399–402. 1998. View Article : Google Scholar : PubMed/NCBI

20 

Neves-Pereira M, Müller B, Massie D, Williams JH, O'Brien PC, Hughes A, Shen SB, Clair DS and Miedzybrodzka Z: Deregulation of EIF4E: A novel mechanism for autism. J Med Genet. 46:759–765. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Kelleher RJ IIIrd and Bear MF: The autistic neuron: Troubled translation? Cell. 135:401–406. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Kao DI, Aldridge GM and Greenough WT: Altered mRNA transport, docking and protein translation in neurons lacking fragile X mental retardation protein. Proc Natl Acad Sci USA. 107:15601–15606. 2010. View Article : Google Scholar

23 

Markram K, Rinaldi T, La Mendola D, Sandi C and Markram H: Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology. 33:901–912. 2008. View Article : Google Scholar

24 

Silva GT, Le Bé JV, Riachi I, Rinaldi T, Markram K and Markram H: Enhanced long-term microcircuit plasticity in the valproic acid animal model of autism. Front Synaptic Neurosci. 1:12009.PubMed/NCBI

25 

Rinaldi T, Perrodin C and Markram H: Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front Neural Circuits. 2:42008. View Article : Google Scholar : PubMed/NCBI

26 

Rinaldi T, Silberberg G and Markram H: Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex. 18:763–770. 2008. View Article : Google Scholar

27 

Rinaldi T, Kulangara K, Antoniello K and Markram H: Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci USA. 104:13501–13506. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Mehta MV, Gandal MJ and Siegel SJ: mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLoS One. 6:e260772011. View Article : Google Scholar : PubMed/NCBI

29 

WalfA AA and Frye CA: The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2:322–328. 2007. View Article : Google Scholar

30 

Fernandes C and File SE: The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav. 54:31–40. 1996. View Article : Google Scholar : PubMed/NCBI

31 

Pellow S, Chopin P, File SE and Briley M: Validation of open:Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 14:149–167. 1985. View Article : Google Scholar : PubMed/NCBI

32 

Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J and Crawley JN: Sociability and preference for social novelty in five inbred strains: An approach to assess autistic-like behavior in mice. Genes Brain Behav. 3:287–302. 2004. View Article : Google Scholar : PubMed/NCBI

33 

Conrad CD, Grote KA, Hobbs RJ and Ferayorni A: Sex differences in spatial and non-spatial Y-maze performance after chronic stress. Neurobiol Learn Mem. 79:32–40. 2003. View Article : Google Scholar

34 

Conrad CD, Galea LA, Kuroda Y and McEwen BS: Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci. 110:1321–1334. 1996. View Article : Google Scholar : PubMed/NCBI

35 

Dellu F, Mayo W, Cherkaoui J, Le Moal M and Simon H: Two-trial memory task with automated recording: Study in young and aged rats. Brain Res. 588:132–139. 1992. View Article : Google Scholar : PubMed/NCBI

36 

Edalatmanesh MA, Nikfarjam H, Vafaee F and Moghadas M: Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism. Brain Res. 1526:15–25. 2013. View Article : Google Scholar : PubMed/NCBI

37 

Lapointe V, Morin F, Ratté S, Croce A, Conquet F and Lacaille JC: Synapse-specific mGluR1-dependent long-term potentiation in interneurones regulates mouse hippocampal inhibition. J Physiol. 15:125–135. 2004. View Article : Google Scholar

38 

Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S and Mizuno N: Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci. 17:7503–7522. 1997.PubMed/NCBI

39 

Patterson PH: Modeling autistic features in animals. Pediatr Res. 69:34R–40R. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Kim KC, Kim P, Go HS, Choi CS, Yang SI, Cheong JH, Shin CY and Ko KH: The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol Lett. 201:137–142. 2010. View Article : Google Scholar

41 

Schneider T and Przewłocki R: Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology. 30:80–89. 2005. View Article : Google Scholar

42 

Kim JE, Shin MS, Seo TB, Ji ES, Baek SS, Lee SJ, Park JK and Kim CJ: Treadmill exercise ameliorates motor disturbance through inhibition of apoptosis in the cerebellum of valproic acid-induced autistic rat pups. Mol Med Rep. 8:327–334. 2013.PubMed/NCBI

43 

Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, Sonders MS, Kanter E, Castagna C, Yamamoto A, et al: Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron. 83:1131–1143. 2014. View Article : Google Scholar : PubMed/NCBI

44 

Nicolini C, Ahn Y, Michalski B, Rho JM and Fahnestock M: Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun. 3:32015. View Article : Google Scholar : PubMed/NCBI

45 

Bear MF, Huber KM and Warren ST: The mGluR theory of fragile X mental retardation. Trends Neurosci. 27:370–377. 2004. View Article : Google Scholar : PubMed/NCBI

46 

Osterweil EK, Krueger DD, Reinhold K and Bear MF: Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci. 30:15616–15627. 2010. View Article : Google Scholar : PubMed/NCBI

47 

Mannaioni G, Marino MJ, Valenti O, Traynelis SF and Conn PJ: Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J Neurosci. 21:5925–5934. 2001.PubMed/NCBI

48 

van Hooft JA, Giuffrida R, Blatow M and Monyer H: Differential expression of group I metabotropic glutamate receptors in functionally distinct hippocampal interneurons. J Neurosci. 20:3544–3551. 2000.PubMed/NCBI

49 

Kullmann DM: Interneuron networks in the hippocampus. Curr Opin Neurobiol. 21:709–716. 2011. View Article : Google Scholar : PubMed/NCBI

50 

Stewart M and Fox SE: Do septal neurons pace the hippocampal theta rhythm? Trends Neurosci. 13:163–168. 1990. View Article : Google Scholar : PubMed/NCBI

51 

Chee SS, Menard JL and Dringenberg HC: The lateral septum as a regulator of hippocampal theta oscillations and defensive behavior in rats. J Neurophysiol. 113:1831–1841. 2015. View Article : Google Scholar : PubMed/NCBI

52 

Lovett-Barron M, Kaifosh P, Kheirbek MA, Danielson N, Zaremba JD, Reardon TR, Turi GF, Hen R, Zemelman BV and Losonczy A: Dendritic inhibition in the hippocampus supports fear learning. Science. 343:857–863. 2014. View Article : Google Scholar : PubMed/NCBI

53 

Han E and Heinemann S: Distal dendritic inputs control neuronal activity by heterosynaptic potentiation of proximal inputs. J Neurosci. 33:1314–1325. 2013. View Article : Google Scholar : PubMed/NCBI

54 

Scharfman HE and Myers CE: Hilar mossy cells of the dentate gyrus: A historical perspective. Front Neural Circuits. 6:1062013. View Article : Google Scholar : PubMed/NCBI

55 

Acsády L, Kamondi A, Sík A, Freund T and Buzsáki G: GABAergic cells are the major postsynaptic targets of mossy fibers in the rat hippocampus. J Neurosci. 18:3386–3403. 1998.PubMed/NCBI

56 

Baude A, Nusser Z, Roberts JD, Mulvihill E, McIlhinney RA and Somogyi P: The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron. 11:771–787. 1993. View Article : Google Scholar : PubMed/NCBI

57 

Techlovská S, Chambers JN, Dvořáková M, Petralia RS, Wang YX, Hájková A, Nová A, Franková D, Prezeau L and Blahos J: Metabotropic glutamate receptor 1 splice variants mGluR1a and mGluR1b combine in mGluR1a/b dimers in vivo. Neuropharmacology. 86:329–336. 2014. View Article : Google Scholar :

58 

Sevastyanova TN and Kammermeier PJ: Cooperative signaling between homodimers of metabotropic glutamate receptors 1 and 5. Mol Pharmacol. 86:492–504. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Peralta F, Fuentealba C, Fiedler J and Aliaga E: Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats. Mol Med Rep 14: 2807-2814, 2016.
APA
Peralta, F., Fuentealba, C., Fiedler, J., & Aliaga, E. (2016). Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats. Molecular Medicine Reports, 14, 2807-2814. https://doi.org/10.3892/mmr.2016.5529
MLA
Peralta, F., Fuentealba, C., Fiedler, J., Aliaga, E."Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats". Molecular Medicine Reports 14.3 (2016): 2807-2814.
Chicago
Peralta, F., Fuentealba, C., Fiedler, J., Aliaga, E."Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats". Molecular Medicine Reports 14, no. 3 (2016): 2807-2814. https://doi.org/10.3892/mmr.2016.5529
Copy and paste a formatted citation
x
Spandidos Publications style
Peralta F, Fuentealba C, Fiedler J and Aliaga E: Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats. Mol Med Rep 14: 2807-2814, 2016.
APA
Peralta, F., Fuentealba, C., Fiedler, J., & Aliaga, E. (2016). Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats. Molecular Medicine Reports, 14, 2807-2814. https://doi.org/10.3892/mmr.2016.5529
MLA
Peralta, F., Fuentealba, C., Fiedler, J., Aliaga, E."Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats". Molecular Medicine Reports 14.3 (2016): 2807-2814.
Chicago
Peralta, F., Fuentealba, C., Fiedler, J., Aliaga, E."Prenatal valproate treatment produces autistic-like behavior and increases metabotropic glutamate receptor 1A-immunoreactivity in the hippocampus of juvenile rats". Molecular Medicine Reports 14, no. 3 (2016): 2807-2814. https://doi.org/10.3892/mmr.2016.5529
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team